IPS HEART has been awarded Orphan Drug Designation (ODD) by the FDA for GIVI-MPCs based on its unique ability to create new muscle with full length dystrophin in Becker Muscular Dystrophy(BMD). IPS ...

The detection of the first clade I mpox case in the U.S. this November, followed by a subsequent case in Canada, is far more ...